Drug Device Combination Products Market

1
Drug Device Combination Products Market Size,
Share Trends Analysis Report and Segment
Forecast, 2024 Grand View Research, Inc
The global drug device combination product
market size was valued at USD 96.3 billion in
2016 and is expected to exhibit a CAGR of 7.9
during the forecast period.
The global Drug Device Combination Product Market
size is expected to reach USD 177.7 billion by
2024, according to a new report by Grand View
Research, Inc., clocking in a 7.9 CAGR during
the forecast period. Rising demand for minimally
invasive techniques due to enhanced patient
outcomes associated with it is the high
impact-rendering driver of this market. These
devices facilitate early diagnosis and reduced
treatment duration in a majority of surgical
procedures. Growing demand is also a consequence
of minimal pain, heightened cost efficiency,
improved safety, better efficacy, rapid
recovery, and reduced hospital stay rendered by
these devices. Increasing presence of regulatory
healthcare authorities enforcing clearly defined
protocols for premarket authorizations is
anticipated to support manufacturers in gaining
approvals for their products. Recently, the U.S.
FDA incorporated the lean management process
mapping approach to build a more cohesive,
streamlined, systematic, and collaborative
system for the review of the aforementioned
products. Safety guidelines and recommendations
issued by these authorities are presumed to
increase the adoption of these products in future
and boost overall growth during the forecast
period.
2

• Severe side effects and drug interactions
  associated with therapeutics owing to drug
  absorption by unintended sites in the body are
  anticipated to induce need for targeted therapy,
  thereby propelling demand for drug-device
  combinations. For instance, consistent
  administration of Levodopa results in long-term
  complications such as motor fluctuations,
  dyskinesias, severe metabolic changes, and
  neurotoxic effects. These aforementioned factors
  drive the clinical urgency to incorporate
  alternatives based on targeted therapy, as in
  case of drug-device combination products.
• To request a sample copy or view summary of this
  report, click the link below
• https//www.grandviewresearch.com/industry-analysi
  s/drug-device-combination-market
• Further key findings from the study suggest
• Transdermal patch held the dominant share by
  product in 2015 owing to increasing demand for
  self- administration of drugs in diseases
  requiring long-term treatment
• The inhalers segment is anticipated to exhibit a
  lucrative CAGR of 9.5 over the forecast period
  owing to rising prevalence of chronic diseases
• North America held the largest share of over
  42.0 in 2015 in terms of region owing to
  extensive new product development activities
  conducted by prominent players across this region
• Asia Pacific is anticipated to grow at a
  lucrative rate over the coming years owing to
  increasing healthcare spending and rising
  awareness levels of physicians pertaining to
  benefits of these products
• Key market players are engaged in various
  strategies such as new product launch and
  distribution agreements to gain market
  penetration. For instance, in February 2016,
  Medtronic introduced the New Resolute Onyx drug-
  eluting stent, commercially available in
  different sizes in Europe, thereby enhancing the
  companys current product offerings
• High operational cost, stringent regulatory
  framework, and capital requirement keep entry
  barriers at a higher level, owing to which,
  threat of new entrants is expected to be low.
• Grand View Research has segmented the global drug
  device combination product market on the basis of
  product type and region
• Drug Device Combination Product Outlook (Revenue,
  USD Billion, 2013 - 2024)
• Infusion Pumps

3

• Volumetric
• Disposables
• Syringes
• Ambulatory
• Implantables
• Insulin
• Orthopedic Combination Products
• Bone Graft Implants
• Antibiotic Bone Cement
• Photodynamic Therapy Devices

4

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Asia Pacific
• Japan
• China
• India

5

• Table of Content of Drug Device Combination
  Products Market
• Chapter 1. Methodology and Scope
• Research Methodology
• Research Scope Assumptions
• List of Data Sources
• Chapter 2. Executive Summary Chapter 3. Market
  Snapshot
• Chapter 4. Market Variables, Trends Scope
• Market segmentation scope
• Market Driver Analysis
• Increasing demand for minimally invasive drug
  delivery devices
• Technological advancements
• Growing popularity of point of care treatment
• Consistent interventions by government healthcare
  organizations
• Increasing awareness levels
• Improving medical reimbursement framework
• Market Restraint Analysis
• High associated costs
• Technical challenges in drug delivery

6

• Syringe
• Syringe market estimates and forecasts, 2013 -
  2024 (USD Billion)
• Ambulatory
• Ambulatory market estimates and forecasts, 2013 -
  2024 (USD Billion)
• Implantable
• Implantable market estimates and forecasts, 2013
  - 2024 (USD Billion)
• Insulin
• Insulin market estimates and forecasts, 2013 -
  2024 (USD Billion)
• Orthopedic Combination Products
• Orthopedic combination products market estimates
  and forecasts, 2013 - 2024 (USD Billion)
• Bone graft implants
• Bone graft implants market estimates and
  forecasts, 2013 - 2024 (USD Billion)
• Antibiotic bone cement
• Antibiotic bone cement market estimates and
  forecasts, 2013 - 2024 (USD Billion)
• Photodynamic Therapy Devices
• Photodynamic therapy devices market estimates and
  forecasts, 2013 - 2024 (USD Billion)
• Transdermal Patches
• Transdermal patches market estimates and
  forecasts, 2013 - 2024 (USD Billion)
• Drug Eluting Stents

7

• Metered dose
• Metered dose market estimates and forecasts, 2013
  - 2024 (USD Billion)
• Antimicrobial Catheters
• Antimicrobial catheters market estimates and
  forecasts, 2013 - 2024 (USD Billion)
• Urological
• Urological market estimates and forecasts, 2013 -
  2024 (USD Billion)
• Cardiovascular
• Cardiovascular market estimates and forecasts,
  2013 - 2024 (USD Billion)
• Others
• Others market estimates and forecasts, 2013 -
  2024 (USD Billion)
• Others
• Others market estimates and forecasts, 2013 -
  2024 (USD Billion)
• Chapter 6. Market Categorization 4 Regional
  Estimates Trend Analysis, By Product,
  Application Test
• Drug Device Combination Market Share By Region,
  2015 2024
• North America
• North America market estimates and forecasts, by
  product, 2013 - 2024 (USD Billion)
• U.S. market estimates and forecasts
• Canada market estimates and forecasts
• Europe

8

• MEA
• MEA market estimates and forecasts, by product,
  2013 - 2024 (USD Billion)
• South Africa market estimates and forecasts
• Chapter 7. Competitive Landscape
• Strategy framework
• Market participation categorization
• Company Profiles
• Abbott Laboratories
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Terumo Corporation
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Stryker Corporation
• Company overview

9

• 7.3.5.4. Strategic initiatives
• St.Jude Medical, Inc.
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Allergan, Plc
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Boston Scientific Corporation
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives
• Novartis AG
• Company overview
• Financial performance

10

• W.L.Core Associates, Inc.
• Company overview
• Financial performance
• Product benchmarking
• Strategic initiatives

About Us Grand View Research, Inc. is a U.S.
based market research and consulting company,
registered in the State of California and
headquartered in San Francisco. The company
provides syndicated research reports, customized
research reports, and consulting services. To
help clients make informed business decisions,
the company offers market intelligence studies
ensuring relevant and fact-based research across
a range of industries including technology,
chemicals, materials, healthcare and
energy. Contact Sherry James Corporate Sales
Specialist, USA
11
Grand View Research, Inc Phone 1-415-
349-0058 Toll Free 1-888- 202-9519 Email
sales_at_grandviewresearch.com For More Information
https//www.grandviewresearch.com Blog
https//healthcareforecastreport.blogspot.com/